Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
about
Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials.Pancreatic cancer biomarkers and their implication in cancer diagnosis and epidemiology.Combined modality treatments in pancreatic cancer.Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial.
P2860
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@en
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@nl
type
label
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@en
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@nl
prefLabel
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@en
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@nl
P2860
P356
P1476
Neoadjuvant treatment for resectable pancreatic cancer: time for phase III testing?
@en
P2093
Michele Reni
P2860
P304
P356
10.3748/WJG.V16.I39.4883
P407
P577
2010-10-01T00:00:00Z